What topics are covered in Brokerage Free articles?

The blog covers stock markets, investing, mutual funds, insurance, taxation, and financial awareness.

Are the articles beginner-friendly?

Yes. The content is written in a simple way so beginners can understand it more easily.

Does the blog include stock market education?

Yes. Readers can find articles about market basics, trading ideas, and investment learning.

Can I read about mutual funds and insurance here?

Yes. The blog includes articles related to mutual funds, insurance, and long-term financial planning.

Are new articles added regularly?

Yes. New articles are added based on financial topics, market trends, and reader interest.

GENERAL FINANCE CORPORATE ACTIONS LISTINGS RESULTS CALENDAR MUTUAL FUNDS GENERAL INSURANCE BROKERS' SPACE GENERAL FINANCE LOANS

Select Category for: Listings

June 1, 2026 4 min read • 237 views

The ₹138 Cr Nutrition IPO Opening June 5 — Here’s Everything You Must Know Before Bidding

Hexagon Nutrition, India's 33-year-old research-driven nutrition powerhouse, hits Dalal Street on June 5, 2026. An in-depth breakdown of financials, risks, valuation, and whether this is a buy, hold, or pass for smart investors

April 28, 2026 4 min read • 1105 views

India’s REIT Yield War: Can Bagmane Beat Embassy & Brookfield at Their Own Game?

A deep-dive into India’s REIT yield landscape—compare Embassy, Brookfield, Mindspace, Nexus, and the upcoming Bagmane REIT. Discover real yields, hidden risks, and whether this IPO could redefine income investing in India

April 28, 2026 5 min read • 422 views

OnEMI IPO Decoded: India’s Next Big Fintech Bet or a Hidden Credit Risk?

OnEMI Technology Solutions IPO explained with full data-backed analysis—financials, valuation, peer comparison, risks, and subscription strategy. Is this fintech IPO worth your money

April 8, 2026 4 min read • 1377 views

Om Power Transmission IPO: Strong Orders… But Where’s the Cash?

Om Power Transmission IPO review: Strong ₹744 Cr order book vs rising working capital risk. Should you apply? Full data-backed analysis

March 25, 2026 3 min read • 1521 views

🧪 Sai Parenterals IPO: ₹408 Cr Pharma Bet Trading at 70–110x — Growth Story or Overvaluation?

Sai Parenterals IPO analysis with RHP data: financials, valuation (70–110x P/E), risks, and growth outlook. Should you invest or avoid? Full forensic breakdown

March 25, 2026 4 min read • 1519 views

⚡ Powerica IPO: Balance Sheet Fix or Strategic Energy Play?

Powerica IPO analysis 2026: Deep dive into financials, RHP insights, valuation, risks, peer comparison, and listing outlook. Should you apply or avoid? Read this expert breakdown before investing

February 25, 2026 4 min read • 1811 views

Clean Max Enviro Energy IPO Analysis: Deleveraging Renewable Platform or High-Risk Infra Bet?

A deep institutional analysis of Clean Max Enviro Energy Solutions IPO covering valuation, leverage risk, C&I renewable positioning, peer comparison, and long-term investment outlook for serious investors

February 25, 2026 4 min read • 1719 views

Gaudium IVF IPO Analysis: Growth Opportunity in India’s Fertility Boom or High-Risk Expansion Bet?

Comprehensive Gaudium IVF IPO analysis covering valuation, bull vs bear case, listing gain potential, risks, and long-term investment outlook

February 7, 2026 4 min read • 1888 views

Aye Finance IPO: Premium Deep-Dive for Informed Investors

In-depth Aye Finance IPO analysis covering valuation vs peers, price band impact, risks, and retail vs HNI subscription strategy to help investors decide wisely

February 7, 2026 4 min read • 2178 views

Fractal Analytics IPO Review: India’s First AI IPO – Hype, Quality, or Valuation Trap?

Fractal Analytics IPO analysis from a fund-manager lens. Deep dive into valuation, DRHP risks, client concentration, ESOP dilution, GMP outlook, and whether investors should apply or avoid this AI-led services IPO